Xiaocui Zhou

427 total citations
11 papers, 302 citations indexed

About

Xiaocui Zhou is a scholar working on Molecular Biology, Infectious Diseases and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Xiaocui Zhou has authored 11 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Infectious Diseases and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Xiaocui Zhou's work include Pancreatic and Hepatic Oncology Research (2 papers), Cancer Research and Treatments (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). Xiaocui Zhou is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Cancer Research and Treatments (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). Xiaocui Zhou collaborates with scholars based in China, Australia and United States. Xiaocui Zhou's co-authors include Qiuju Wang, Chuang Xu, Yizhe Cui, Renxu Chang, Jingjiao Zhou, Yan Wang, Jun Wang, Bing He, Yuanyuan Wang and Yuan Yuan and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Agricultural and Food Chemistry and Frontiers in Immunology.

In The Last Decade

Xiaocui Zhou

11 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaocui Zhou China 9 128 103 46 45 35 11 302
Françoise Mercier‐Nomé France 9 159 1.2× 117 1.1× 55 1.2× 20 0.4× 41 1.2× 18 364
Olja Stevanović Serbia 4 244 1.9× 232 2.3× 89 1.9× 57 1.3× 53 1.5× 7 438
Su Xu China 13 258 2.0× 59 0.6× 40 0.9× 87 1.9× 17 0.5× 30 521
Yurong Lu China 12 180 1.4× 65 0.6× 37 0.8× 149 3.3× 27 0.8× 19 557
Dorota Mańkowska‐Wierzbicka Poland 10 162 1.3× 50 0.5× 31 0.7× 51 1.1× 29 0.8× 32 305
Zhenhuang Ge China 8 247 1.9× 102 1.0× 114 2.5× 26 0.6× 31 0.9× 13 382
Olena Tsyryuk Ukraine 10 113 0.9× 91 0.9× 66 1.4× 23 0.5× 60 1.7× 21 279
Aleksandra Radovanović Spurnić Serbia 4 229 1.8× 224 2.2× 88 1.9× 42 0.9× 55 1.6× 11 423
Ivana Gmizić Serbia 3 229 1.8× 224 2.2× 88 1.9× 52 1.2× 52 1.5× 6 412
Jiang Tan China 11 155 1.2× 72 0.7× 37 0.8× 13 0.3× 26 0.7× 19 488

Countries citing papers authored by Xiaocui Zhou

Since Specialization
Citations

This map shows the geographic impact of Xiaocui Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaocui Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaocui Zhou more than expected).

Fields of papers citing papers by Xiaocui Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaocui Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaocui Zhou. The network helps show where Xiaocui Zhou may publish in the future.

Co-authorship network of co-authors of Xiaocui Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaocui Zhou. A scholar is included among the top collaborators of Xiaocui Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaocui Zhou. Xiaocui Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Wang, Yi, Xiaoxia Wang, Laurence Don Wai Luu, et al.. (2022). Proteomic and Metabolomic Signatures Associated With the Immune Response in Healthy Individuals Immunized With an Inactivated SARS-CoV-2 Vaccine. Frontiers in Immunology. 13. 848961–848961. 22 indexed citations
2.
Jin, Gang, Shiwei Guo, Yanqiao Zhang, et al.. (2022). A phase II study of KN046 monotherapy as 2nd line and above treatment for unresectable locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC).. Journal of Clinical Oncology. 40(16_suppl). e16305–e16305. 4 indexed citations
3.
Jin, Gang, Shiwei Guo, Yanqiao Zhang, et al.. (2021). Efficacy and safety of KN046 plus nab-paclitaxel/gemcitabine as first-line treatment for unresectable locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC).. Journal of Clinical Oncology. 39(15_suppl). 4138–4138. 12 indexed citations
4.
Li, Meng, Shun Wu, You Li, et al.. (2020). LIGHT deficiency aggravates cisplatin-induced acute kidney injury by upregulating mitochondrial apoptosis. International Immunopharmacology. 89(Pt A). 106999–106999. 11 indexed citations
5.
He, Bing, Jun Wang, Yudie Wang, et al.. (2020). The Metabolic Changes and Immune Profiles in Patients With COVID-19. Frontiers in Immunology. 11. 2075–2075. 35 indexed citations
7.
Deng, Hongkuan, Jian Zhou, Binbin Gong, et al.. (2019). Screening and identification of a human domain antibody against Brucella abortus VirB5. Acta Tropica. 197. 105026–105026. 8 indexed citations
8.
Cui, Yizhe, Renxu Chang, Tao Zhang, et al.. (2019). Chinese Herbal Formula (CHF03) Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) Through Inhibiting Lipogenesis and Anti-Oxidation Mechanisms. Frontiers in Pharmacology. 10. 1190–1190. 14 indexed citations
9.
Cui, Yizhe, Qiuju Wang, Renxu Chang, Xiaocui Zhou, & Chuang Xu. (2019). Intestinal Barrier Function–Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut Microbiota. Journal of Agricultural and Food Chemistry. 67(10). 2754–2762. 163 indexed citations
10.
11.
Zhou, Xiaocui, David Lefebvre, Sandrine Lacour, et al.. (2018). A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs. Vaccine. 36(16). 2193–2198. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026